Raffaele Iorio

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard, Kimiaki Utsugisawa, Michael Benatar et al. · The Lancet Neurology · 2017 · 745 citations

Multicentre Study, Pharmacology, Medicine +3

Updated estimate of AQP4-IgG serostatus and disability outcome in neuromyelitis optica

Yujuan Jiao, James P. Fryer, Vanda A. Lennon et al. · Neurology · 2013 · 236 citations · Full text

Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study

Vera Bril, Artur Drużdż, Julian Großkreutz et al. · The Lancet Neurology · 2023 · 227 citations

Clinical Trials, Generalised Myasthenia Gravis, Pharmacotherapy +3

Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study

James F. Howard, Saskia Bresch, Angela Genge et al. · The Lancet Neurology · 2023 · 213 citations

Medicine, Surgery, Clinical Trials +1

Clinical and immunological characteristics of the spectrum of GFAP autoimmunity: a case series of 22 patients

Raffaele Iorio, Valentina Damato, Amelia Evoli et al. · Journal of Neurology Neurosurgery & Psychiatry · 2017 · 203 citations